Client Alerts & Insights
OIG Addresses Financial Incentives for Employees and Residents who Refer New Residents to CCRCs in Advisory Opinion 10-05
June 1, 2010
On May 19, 2010, The U.S. Department of Health and Human Services Office of the Inspector General (“OIG”) released its Advisory Opinion 10-05. The opinion addresses a financial incentive or “Rewards” program (the “Arrangement”) for referrals of potential new residents to Continuing Care Retirement Communities (“CCRC”) which provide independent living, assisted living, and skilled nursing services to residents on one campus.
The Arrangement discussed in the opinion has two parts:
- a Gift Card program where current residents or employees can receive a gift card when they recommend the independent living community to a prospective resident. They can receive the gift card if the resident or employee submits the prospective resident’s name and contact information to the CCRC, the prospective resident is eligible to enter a continuing care contract, and the prospective resident tours the community within ninety (90) days; and
- a credit/reward program for independent living referrals if a prospective resident moves into the independent living community within twelve (12) months of a tour of the facility. A resident who made the referral can receive a one-time credit toward his or her monthly CCRC fee. An employee that made a referral will receive a check for a specified amount.
The OIG concludes that the Arrangement would not generate prohibited remuneration under section 1128(b) of the Social Security Act (Act), the federal Anti-Kickback Statute and the OIG would not impose sanctions as a result of its conclusions. The OIG’s conclusions were primarily based upon the following facts and issues:
- The Arrangement was focused on attracting new members to the CCRC’s independent living services and the independent living services are not reimbursable by a federal healthcare program.
- Neither of the rewards programs apply to residents who move directly into assisted living or skilled nursing units.
- Services provided in the skilled nursing and assisted living units are reimbursable by federal healthcare plans, and some residents may require these services from years into the future, but most will not.
- Whether an individual resident referred by a current resident or employee will actually end up needing services that are reimbursable by a federal healthcare program at some point in the future is substantially speculative and outside the control of the current resident or employee.
While the OIG’s conclusions are not that surprising given the facts of the Arrangement, the opinion does provide a reminder of the issues that the OIG will evaluate in whether or not a resident/patient referral program (or marketing incentives in general) would run-afoul of the Federal Anti-Kickback Statute.
For example, the OIG analysis suggests that it might have concluded differently if:
- the referrals were made based on the health care needs of the prospective residents;
- the referrals were made by individuals (such as physicians) who were in a position to influence medical decision-making; or
- the referrals were made by individuals in positions of trust (such as physicians) who are able to exert undue influence over recommendations of healthcare items and services.
When considering an incentive program for resident/patient referrals, providers should take into account OIG guidance on these issues and the specific factors the OIG has used to evaluate these types of arrangements.
Additional Information
For more information on Advisory Opinion 10-05, the Anti-Kickback Statute, resident/patient referral programs or other related issues, please contact a member of Benesch’s Health Care Department:
Cleveland
Harry Brown at 216.363.4606 or hbrown@beneschlaw.com
Alan Schabes at 216.363.4589 or aschabes@beneschlaw.com
Columbus
Janet Feldkamp at 614.223.9328 or jfeldkamp@beneschlaw.com
Latest News
Supreme Court Clarifies Judicial Estoppel Standard in Bankruptcy Nondisclosure Cases
The U.S. Supreme Court rejected a rigid rule that often blocked debtors from pursuing claims they failed to disclose in bankruptcy. Courts must now look at the full circumstances before deciding whether an omission was intentional or an honest mistake.
Federal Court Hands Major Win to Tissue Product Manufacturers – FDA’s HCT/P Classification Decision for Umbilical Cord–Derived Product CORDGRAFT Rejected
On March 18, 2026, Chief Judge Brian C. Wimes of the U.S. District Court for the Western District of Missouri issued a significant decision overturning the U.S. Food and Drug Administration’s (“FDA”) classification of Vitti Labs’ umbilical cord–derived product, CORDGRAFT.
Science-Backed But Not FDA-Approved: New Lawsuit Challenges FDA’s Rejection of 114 Health-Related Advertising Claims
A new lawsuit challenges the FDA’s rejection of 114 health-related advertising claims for supplements, arguing that the agency’s narrow interpretation of what counts as an “authoritative statement” unfairly blocks science-backed—but not FDA-approved—claims from appearing on product labels.
When ChatGPT Lies: What the First Wave of AI Defamation Cases Means for Plaintiffs
The common argument made by plaintiffs that differences in alleged misrepresentations are transcended by the center of the gravity of the alleged fraud should not be addressed through the typical approach of just comparing the level of variance of the representations in the case at issue with that in the relevant precedent.